This achievement, published in The New England Journal of Medicine on May 15, 2025, marks a shift from science fiction to reality, highlighting potential for future genetic disease treatments. Led by Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunuru, it underscores collaborative medical innovation.
